Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48399936120c5918b9f29ea5fee7ff0b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 |
filingDate |
1990-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1996-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2dda432814a38a9d626c9f61dbc57ab |
publicationDate |
1996-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0458861-B1 |
titleOfInvention |
Composition for reparation and prevention of fibrotic lesions |
abstract |
The composition comprising 5-methyl-2-(1H)-pyridone is effective for the reparation and prevention of fibrotic lesions as in life-threatening asbestosis. 5-methyl-1-phenyl-2-(1H)-pyridone exerts on the anti-fibrotic activity quite dissimilar to and independent of fibrinolytic activity. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9018232-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383823-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7825133-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8680123-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9504677-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8022087-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969576-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969575-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9062001-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022015141-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8084465-B2 |
priorityDate |
1989-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |